335 FIBROINDEX (NONINVASIVE MARKERS OF LIVER FIBROSIS) CAN PREDICT HCC DEVELOPMENT AND MORTALITY IN PATIENTS WITH CHRONIC HEPATITIS C
β Scribed by M. Koda; Y. Fujise; S. Tokunaga; M. Kishina; J. Kato; T. Matono; Y. Murawaki
- Book ID
- 117379480
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 41 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
HCV infection is common among patients with end-stage renal disease (ESRD) on hemodialysis, and it has been considered an independent risk factor for mortality in this setting. Although liver biopsy in ESRD patients with HCV infection is useful before kidney transplantation, it carries a high risk o
Liver fibrosis is the main predictor of the progression of chronic hepatitis C, and its assessment by liver biopsy (LB) can help determine therapy. However, biopsy is an invasive procedure with several limitations. A new, noninvasive medical device based on transient elastography has been designed t